OSE IMMUNO (OSE.PA) Stock Price, Quote, News and Overview
EPA:OSE - Euronext Paris - Matif - FR0012127173 - Common Stock - Currency: EUR
OSE.PA Quote, Performance and Key Statistics
EPA:OSE (5/9/2025, 7:00:00 PM)
6.005
+0.14 (+2.39%)
The current stock price of OSE.PA is 6.005 EUR. In the past month the price increased by 7.71%. In the past year, price decreased by -11.04%.
OSE.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 18.35 | 295.07B | ||
| 1ABBV.MI | ABBVIE INC | 18.28 | 294.00B | ||
| AMG.DE | AMGEN INC | 13.05 | 128.98B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 12.71 | 108.39B | ||
| GIS.DE | GILEAD SCIENCES INC | 12.57 | 107.23B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 1474.42 | 98.55B | ||
| ARGX.BR | ARGENX SE | 104.64 | 30.29B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 20.04B | ||
| IDP.DE | BIOGEN INC | 7.55 | 15.50B | ||
| 0QF.DE | MODERNA INC | N/A | 8.54B | ||
| 1MRNA.MI | MODERNA INC | N/A | 8.14B | ||
| BIO.DE | BIOTEST AG | 65.54 | 1.69B |
Related stock screener links
About OSE.PA
Company Profile
OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. The company is headquartered in Nantes, Pays De La Loire. The company went IPO on 2015-03-30. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.
Company Info
OSE IMMUNO
22, boulevard Benoni Goullin
Nantes PAYS DE LA LOIRE FR
Employees: 52
Phone: 33228291010
OSE IMMUNO / OSE.PA FAQ
What is the stock price of OSE IMMUNO today?
The current stock price of OSE.PA is 6.005 EUR. The price increased by 2.39% in the last trading session.
What is the ticker symbol for OSE IMMUNO stock?
The exchange symbol of OSE IMMUNO is OSE and it is listed on the Euronext Paris - Matif exchange.
On which exchange is OSE.PA stock listed?
OSE.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for OSE IMMUNO stock?
9 analysts have analysed OSE.PA and the average price target is 16.83 EUR. This implies a price increase of 180.27% is expected in the next year compared to the current price of 6.005. Check the OSE IMMUNO stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is OSE IMMUNO worth?
OSE IMMUNO (OSE.PA) has a market capitalization of 134.21M EUR. This makes OSE.PA a Micro Cap stock.
How many employees does OSE IMMUNO have?
OSE IMMUNO (OSE.PA) currently has 52 employees.
What are the support and resistance levels for OSE IMMUNO (OSE.PA) stock?
OSE IMMUNO (OSE.PA) has a support level at 5.32 and a resistance level at 6.6. Check the full technical report for a detailed analysis of OSE.PA support and resistance levels.
Is OSE IMMUNO (OSE.PA) expected to grow?
The Revenue of OSE IMMUNO (OSE.PA) is expected to decline by -47.32% in the next year. Check the estimates tab for more information on the OSE.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy OSE IMMUNO (OSE.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OSE.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OSE.PA, evaluating the profitability, health, valuation and growth aspects
- OSE IMMUNO (OSE.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OSE IMMUNO (OSE.PA) Sales and EPS estimates to see what analysts future expectations are.
- OSE IMMUNO (OSE.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OSE IMMUNO (OSE.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- OSE IMMUNO (OSE.PA) Stock Chart to make your own analysis
- OSE IMMUNO (OSE.PA) Latest news and press-releases to stay up to date.
Does OSE IMMUNO (OSE.PA) stock pay dividends?
OSE.PA does not pay a dividend.
When does OSE IMMUNO (OSE.PA) report earnings?
OSE IMMUNO (OSE.PA) will report earnings on 2025-09-24.
What is the Price/Earnings (PE) ratio of OSE IMMUNO (OSE.PA)?
The PE ratio for OSE IMMUNO (OSE.PA) is 4.06. This is based on the reported non-GAAP earnings per share of 1.48 and the current share price of 6.005 EUR. Check the full fundamental report for a full analysis of the valuation metrics for OSE.PA.
OSE.PA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to OSE.PA. When comparing the yearly performance of all stocks, OSE.PA is a bad performer in the overall market: 78.96% of all stocks are doing better.
OSE.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to OSE.PA. While OSE.PA has a great health rating, its profitability is only average at the moment.
OSE.PA Financial Highlights
Over the last trailing twelve months OSE.PA reported a non-GAAP Earnings per Share(EPS) of 1.48. The EPS increased by 225.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 44.88% | ||
| ROA | 30.21% | ||
| ROE | 58.68% | ||
| Debt/Equity | 0.6 |
OSE.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to OSE.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -82.85% and a revenue growth -47.32% for OSE.PA